"We thank Bernie and Michael for their years of dedication and service as board members and deeply appreciate David's commitment to leading our board and guiding us through this dynamic period in our evolution as a company," added Dr. Kogan.
Ms. Brown currently serves on the boards of Targacept, Inc., a company engaged in development of neuronal nicotinic receptor therapeutics and Biodel Inc., a specialty pharmaceutical company. She chairs the compensation committee of both boards and serves on the nominating and governance committee for Biodel. Julia previously served on the boards of Trius Therapeutics, Inc., Tanox, Inc. (acquired by Genentech, Inc.), CovX (acquired by Pfizer, Inc.), Labopharm, Inc. (acquired by Paladin Labs Inc.), and MediQuest Therapeutics, Inc.
From 2000 to 2003, Ms. Brown was Executive Vice President of Amylin Pharmaceuticals, Inc. and served as Advisor to the Chief Executive Officer until 2008. From 1995 to 1999, she worked for Dura Pharmaceuticals, Inc., finishing her tenure as Executive Vice President. Prior to this, Julia spent over 25 years with Eli Lilly and Company in progressively more senior roles. From 1992 to 1994, Julia was Vice President of IVAC Corporation and General Manager of its Vital Signs Division (a Lilly subsidiary). She was Vice President of Worldwide Marketing for Hybritech (another Lilly subsidiary), and led global marketing from 1986-1992. Ms. Brown holds a Bachelor of Science in Microbiology from Louisiana Tech University.
Mr. Principi currently serves on the boards of Engility Holdings, Inc., a government services contractor; Mutual of Omaha, a life insurance company; A.T. Kearney PSDS, a management consulting firm; the Lung Cancer Alliance, a non-profit patient support and advocacy group and the Wounded Warrior Project, a non-profit that provides programs and services to severely injured service members during their transition between active duty and civilian life. From 2006 to 2011, he was Senior Vice President of Government Relations at Pfizer, Inc. Prior to joining Pfizer, Mr. Principi served as the 4th United States Secretary of Veterans Affairs from 2001 to 2005, appointed by President George W. Bush. In 2005, Anthony was appointed to chair the Military Base Realignment and Closure Commission that was responsible for recommending to the President and Congress the realignment and closure of military installations throughout the United States.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV